Literature DB >> 23109755

Simultaneous very late stent thrombosis in multiple coronary arteries.

Seshasayee Narasimhan1, Nassim Rostane Krim, Gary Silverman, Ernest Scott Monrad.   

Abstract

We report 2 noteworthy cases of very late stent thrombosis presenting as ST-segment-elevation myocardial infarction, with vastly different manifestations. Both patients were women who had histories of multivessel percutaneous coronary intervention with first-generation sirolimus-eluting stents, in 2005 and 2006. On the more recent occasions reported here, one underwent successful multivessel primary percutaneous coronary intervention, while the other underwent successful multivessel "plain old balloon angioplasty." Both were discharged from the hospital with advice to stop smoking and to follow a lifelong regimen of aspirin and clopidogrel.On the basis of these two cases and our review of the current literature, we ask whether it is now prudent to recommend lifelong dual antiplatelet therapy after drug-eluting stent deployment. Moreover, in order to account for cases of stent thrombosis that occur ≥ 5 years after drug-eluting stent implantation, should we perhaps suggest the addition of "extremely late stent thrombosis" to the existing Academic Research Consortium classification?

Entities:  

Keywords:  Aspirin; ST-elevation myocardial infarction; clopidogrel; coronary restenosis/etiology; coronary thrombosis/etiology; drug delivery systems/adverse effects; immunosuppressive agents; paclitaxel; platelet aggregation inhibitors/therapeutic use; sirolimus/therapeutic use; stent thrombosis; stents, drug-eluting/adverse effects; very late stent thrombosis

Mesh:

Substances:

Year:  2012        PMID: 23109755      PMCID: PMC3461685     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  25 in total

1.  Stent fracture and restenosis in the drug-eluting stent era.

Authors:  Georgios Sianos; Sjoerd Hofma; Jurgen M R Ligthart; Francesco Saia; Angela Hoye; Pedro A Lemos; Patrick W Serruys
Journal:  Catheter Cardiovasc Interv       Date:  2004-01       Impact factor: 2.692

2.  Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?

Authors:  Babak Azarbal; Jesse W Currier
Journal:  J Am Coll Cardiol       Date:  2005-11-22       Impact factor: 24.094

3.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

4.  Stent thrombosis in randomized clinical trials of drug-eluting stents.

Authors:  Laura Mauri; Wen-hua Hsieh; Joseph M Massaro; Kalon K L Ho; Ralph D'Agostino; Donald E Cutlip
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

5.  Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Authors:  Pramod K Kuchulakanti; William W Chu; Rebecca Torguson; Patrick Ohlmann; Seung-Woon Rha; Leonardo C Clavijo; Sang-Wook Kim; Ahn Bui; Natalie Gevorkian; Zhenyi Xue; Kimberly Smith; Jana Fournadjieva; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

6.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

Review 7.  Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.

Authors:  Jun-ichi Kotani; Masaki Awata; Shinsuke Nanto; Masaaki Uematsu; Fusako Oshima; Hitoshi Minamiguchi; Gary S Mintz; Seiki Nagata
Journal:  J Am Coll Cardiol       Date:  2006-04-04       Impact factor: 24.094

8.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

Authors:  Joost Daemen; Peter Wenaweser; Keiichi Tsuchida; Linda Abrecht; Sophia Vaina; Cyrill Morger; Neville Kukreja; Peter Jüni; Georgios Sianos; Gerrit Hellige; Ron T van Domburg; Otto M Hess; Eric Boersma; Bernhard Meier; Stephan Windecker; Patrick W Serruys
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

9.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

Review 10.  Drug-eluting stents: caution and concerns for long-term outcome.

Authors:  Renu Virmani; Andrew Farb; Giulio Guagliumi; Frank D Kolodgie
Journal:  Coron Artery Dis       Date:  2004-09       Impact factor: 1.439

View more
  5 in total

1.  The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment.

Authors:  Yong-Juan Lin; Jing-Wei Li; Mei-Juan Zhang; Lai Qian; Wen-Jie Yang; Chun-Lei Zhang; Yuan Shao; Yang Zhang; Yu-Jie Huang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2013-12-12       Impact factor: 5.243

2.  Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.

Authors:  Masahiro Yamawaki; Yoshinobu Onuma; Masatsugu Nakano; Takashi Muramatsu; Shimpei Nakatani; Yuki Ishibashi; Hiroshi Ishimori; Keisuke Hirano; Yoshiaki Ito; Reiko Tsukahara; Toshiya Muramatsu
Journal:  Heart Vessels       Date:  2014-07-17       Impact factor: 2.037

3.  Extremely late stent thrombosis after more than 7 years (2691 days) of sirolimus-eluting stent implantation.

Authors:  Deniz Demirci; Dugu Ersan Demirci; Şakir Arslan
Journal:  Anatol J Cardiol       Date:  2018-03-13       Impact factor: 1.596

4.  Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian.

Authors:  George Kassimis; Tushar Raina
Journal:  J Geriatr Cardiol       Date:  2018-10       Impact factor: 3.327

5.  Simultaneous Multi-Vessel Very Late Stent Thrombosis in Acute ST-Segment Elevation Myocardial Infarction.

Authors:  Yuefeng Chen; Michael Amponsah; Cyril Nathaniel
Journal:  Case Rep Cardiol       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.